Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
15.53
+0.18 (1.17%)
At close: Apr 24, 2026, 4:00 PM EDT
15.84
+0.31 (2.00%)
After-hours: Apr 24, 2026, 7:10 PM EDT
Olema Pharmaceuticals Market Cap
Olema Pharmaceuticals has a market cap or net worth of $1.35 billion as of April 24, 2026. Its market cap has increased by 528.83% in one year.
Market Cap
1.35B
Enterprise Value
852.30M
1-Year Change
528.83%
Ranking
Category
Stock Price
$15.53
Market Cap Chart
Since the IPO on November 19, 2020, Olema Pharmaceuticals's market cap has decreased from $1.79B to $1.35B, a decrease of -24.58%. That is a compound annual growth rate of -5.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 1.35B | -31.17% |
| Dec 31, 2025 | 1.97B | 357.26% |
| Dec 31, 2024 | 430.06M | -43.88% |
| Dec 29, 2023 | 766.34M | 679.84% |
| Dec 30, 2022 | 98.27M | -73.58% |
| Dec 31, 2021 | 372.01M | -79.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 19, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Maze Therapeutics | 1.44B |
| Iovance Biotherapeutics | 1.43B |
| Wave Life Sciences | 1.41B |
| Precigen | 1.40B |
| ArriVent BioPharma | 1.37B |
| Corvus Pharmaceuticals | 1.35B |
| Novavax | 1.33B |
| MapLight Therapeutics | 1.28B |